Archer Daniels Midland (ADM)
(Delayed Data from NYSE)
$58.86 USD
-0.37 (-0.62%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $58.83 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$58.86 USD
-0.37 (-0.62%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $58.83 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Zacks News
Clorox's Annual Report Reveals Significant Progress, Stock Up
by Zacks Equity Research
Clorox (CLX) issues its integrated annual report for fiscal 2018, which marks the seventh consecutive year of the release.
USMCA (aka NAFTA 2.0): Here Are the Winners & Losers
by Tirthankar Chakraborty
Who's smiling and who's not as the world witnesses the making of the new NAFTA?
The Zacks Analyst Blog Highlights: Acelor Mittal, Archer Daniels Midland and Nucor
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Acelor Mittal, Archer Daniels Midland and Nucor
All About the JOBS Report: Global Week Ahead
by John Blank
This Global Week Ahead should key largely on a looming U.S. jobs report. Friday's U.S. nonfarm payroll release for September may show us two things.
Is Archer Daniels Midland (ADM) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (ADM) Outperforming Other Consumer Staples Stocks This Year?
Can Clorox's (CLX) Growth Strategies Offset Margin Woes?
by Zacks Equity Research
Clorox's (CLX) solid growth strategies, including 2020 Strategy, bode well. These initiatives are likely to offset margin pressures moving ahead.
Trump Clinches Trade Deal With South Korea: 6 Winning Picks
by Swarup Gupta
Trump claims that U.S. auto, pharma and agricultural products will gain from the deal with South Korea.
5 Defensive Stocks to Buy as Trade Tensions Take a New Turn
by Ritujay Ghosh
Given that both the United States and China are imposing tit-for-tat tariffs, the trade war is unlikely to end anytime soon.
Avon Stock Rallies on Takeover Talks With Brazil's Natura
by Zacks Equity Research
Avon (AVP) gains on rumors of a possible buyout by Natura & Co, the leading Brazilian cosmetics company.
4 Reasons Why You Should Invest in Archer Daniels Stock
by Zacks Equity Research
Archer Daniels' (ADM) progresses on its portfolio management initiatives, cost-savings plan and Readiness program bodes well.
Is Archer Daniels Midland (ADM) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (ADM) Outperforming Other Consumer Staples Stocks This Year?
Can AB InBev (BUD) Break Fall Even as Beer Brands Lose Fizz?
by Zacks Equity Research
AB InBev (BUD) suffers due to industry-wide decline in beer sales as consumers shift to healthier drinks. However, the company???s robust outlook indicates that there is an upside potential.
Chefs' Warehouse (CHEF) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Chefs' Warehouse (CHEF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE
Top Research Reports for Abbott, Gilead & FedEx
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Abbott (ABT), Gilead (GILD) and FedEx (FDX).
Zacks.com highlights: Avnet, Fortinet, Insight Enterprises, Archer Daniels Midland and AMETEK
by Zacks Equity Research
Zacks.com highlights: Avnet, Fortinet, Insight Enterprises, Archer Daniels Midland and AMETEK
5 Stocks Near 52-Week High With Potential to Scale Higher
by Zacks Equity Research
Here are some stocks trading near their 52-week high levels with room for further improvement.
5 Must-Have Stocks for Historically Weak September
by Sweta Killa
Investors should focus on some niche areas that will provide some downside protection in addition to capital appreciation.
Markets Face Multiple Risks in September: 6 Defensive Picks
by Swarup Gupta
Storm clouds are brewing for investors as we enter the historically rocky month of September.
Boston Beer (SAM) Surges Despite Beer Woes: Will it Persist?
by Zacks Equity Research
Boston Beer (SAM) rallies despite industry headwinds, including a soft beer category, a shift to healthier drinks and higher costs. The company's non-beer portfolio shows potential for further growth.
Why Is ADM (ADM) Up 4.8% Since Last Earnings Report?
by Zacks Equity Research
ADM (ADM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
S&P 500 Hits 2,900: Best Performing Stocks YTD
by Sweta Killa
While there are winners from various corners of the space, we have highlighted five stocks on the S&P 500 that have outperformed so far this year.
Earnings Estimates Moving Higher for Archer-Daniels-Midland (ADM): Time to Buy?
by Zacks Equity Research
Archer-Daniels-Midland (ADM) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
5 Top Winners From Trump's $6 Billion Trade Relief Program
by Sreya Bhowmick
Trump rolls out $6 billion relief program for U.S. farmers to counteract trade-war related losses. This calls for bets on top-ranked stocks from the agricultural, poultry and dairy markets.
Newell Feels the Pinch of Soft Q2: Is it Time to Offload?
by Zacks Equity Research
Newell (NWL) disappoints investors with its unimpressive top-line performance. Also, it is witnessing margin constraints for a while now due to cost inflation and adverse product mix.